Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy
Background Genetically engineered T-cell immunotherapies for adoptive cell transfer (ACT) have emerged as a promising form of cancer treatment, but many of these patients develop recurrent disease. Furthermore, delineating mechanisms of resistance may be challenging since the analysis of bulk tumor...
Saved in:
| Main Authors: | Arun Singh, Antoni Ribas, Theodore Scott Nowicki, Katie M Campbell, Anusha Kalbasi, Maneesha Thaker, Egmidio Medina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/3/e004190.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells
by: Kelly-Anne Masterman, et al.
Published: (2020-10-01) -
Mechanism of action of over-expressing NY-ESO-1 in vesicular stomatitis virus and its combination therapy with NY-ESO-1 TCR-T
by: Ting Tian, et al.
Published: (2025-08-01) -
Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma
by: Mara Giavina-Bianchi, et al.
Published: (2015-01-01) -
Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.
by: Agnes S Klar, et al.
Published: (2015-01-01) -
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system
by: Xiaojing Tina Chen, et al.
Published: (2024-12-01)